156 Episoder

  1. How many trillions in damage would an invasion of Taiwan cost global GDP?

    Publisert: 31.7.2024
  2. The Orthogonal Bet: Using Computational Biology to Understand How the Brain Works

    Publisert: 26.7.2024
  3. Evolved Technology: Why technology is counter-intuitively pushing us back to natural products in pharma development

    Publisert: 24.7.2024
  4. The Orthogonal Bet: What the Microsoft Outage Reveals

    Publisert: 19.7.2024
  5. The Orthogonal Bet: The Quest to Find the Poetic Web

    Publisert: 19.7.2024
  6. Pivoting to the Expert Economy

    Publisert: 17.7.2024
  7. The Orthogonal Bet: What AI Can Learn from Human Cognition

    Publisert: 12.7.2024
  8. Can we be optimistic about America’s future?

    Publisert: 10.7.2024
  9. The Orthogonal Bet: Unveiling the Complexity of Life: A Conversation with Philip Ball on ‘How Life Works'

    Publisert: 5.7.2024
  10. “The commons are under attack” from TikTok and subsea cables to data centers and elections

    Publisert: 3.7.2024
  11. The Orthogonal Bet: How to fund R&D that is for the public good?

    Publisert: 28.6.2024
  12. Is AI killing journalism? Pitchforks, Perplexity and reporters yelling “Boo!”

    Publisert: 25.6.2024
  13. The Orthogonal Bet: SimCity, Maxis and the ambitious modeling of everything

    Publisert: 21.6.2024
  14. Why high-throughput bio research needs better tools immediately

    Publisert: 14.6.2024
  15. The Orthogonal Bet: Novelist Robin Sloan’s Love for Books with Maps on the First Page

    Publisert: 7.6.2024
  16. How Applied Intuition used the Valley’s hardest lessons to upgrade automotive with autonomy

    Publisert: 31.5.2024
  17. Orthogonal Bet: A technology vibe shift from utopian Star Trek to absurdist Douglas Adams?

    Publisert: 24.5.2024
  18. The soon-to-be-solved protein problem that will accelerate drug discovery

    Publisert: 17.5.2024
  19. Margaret Mead and the psychedelic community that theorized AI

    Publisert: 3.5.2024
  20. The nightmare specter of designer bioweapons and the people trying to stop them

    Publisert: 26.4.2024

4 / 8

A podcast by venture capital firm Lux Capital on the opportunities and risks of science, technology, finance and the human condition. Hosted by Danny Crichton from our New York City studios.

Visit the podcast's native language site